Metformin and cancer mortality
The author analyses recent publications supporting the ability of metformin to decrease the risk of cancer morbidity and mortality in patients with type 2diabetes mellitus. Pre-history of the problem (including the use of biguanides for metabolic rehabilitation of oncological patients), the role of...
Saved in:
| Main Author: | Lev Mikhaylovich Bershteyn |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2010-09-01
|
| Series: | Сахарный диабет |
| Subjects: | |
| Online Access: | https://www.dia-endojournals.ru/jour/article/view/5491 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hormonal, metabolic and genetic predictors of metformin efficacy in patients with diabetes mellitus and cancer
by: Lev Mikhaylovich Bershteyn, et al.
Published: (2014-03-01) -
Multidimensional effects of metformin in patients with type 2 diabetes
by: Lyudmila A. Ruyatkina, et al.
Published: (2017-08-01) -
Efficacy and safety of metformin for the treatment of gestational diabetes: a new approach to the problem
by: Anna I. Sazonova, et al.
Published: (2016-05-01) -
Diabetes, obesity and cancer: risk and anti-risk factors
by: Lev Mikhaylovich Bershteyn
Published: (2012-12-01) -
Risk of oncological diseases in patients with diabetes mellitus
by: Gagik Radikovich Galstyan
Published: (2009-12-01)